A new international study led by Prof. Carmit Levy of the Department of Human Genetics and Biochemistry at the Gray Faculty of Medical & Health Sciences at Tel Aviv University finds that melanoma ...

Researchers headed by a team at the The Barcelona Institute of Science and Technology (BIST) Centre for Genomic Regulation (CRG) have discovered a protein, eukaryotic translation initiation factor 2A ...

Nine of the 10 most common cancer deaths in Australia are caused by solid tumours, but in most cases it’s the cancer’s spread to other parts of the body – known as metastasis – that proves fatal. Now, ...

The anti-tumor immune response involves a series of complex steps mediated by various immune cells and signaling molecules. Cytotoxic T cells (CTLs), also known as “killer” T cells, play a central ...

A personalised mRNA vaccine developed by Moderna and Merck shows lasting benefits for patients with high-risk skin cancer.

This news could be tough to face. A new report from the Skin Cancer Foundation predicts that 234,680 cases of melanoma will ...

New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and ...

The five-year results come from a phase 2b study that tested intismeran autogene in combination with Merck’s Keytruda in ...

Moderna and Merck's melanoma vaccine, combined with Keytruda, could halve cancer recurrence risk, marking a breakthrough in ...